Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

NCT07283640

Conditions: Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: MD Anderson Cancer Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

NCT07192237

Conditions: Acute Lymphoblastic Leukemia, Blinatumomab, Hematologic Diseases, +11 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

NCT07021989

Conditions: Classic Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
Locations: University of California Davis Davis, California, United States

University of California San Francisco-Fresno Fresno, California, United States

University of California Irvine Irvine, California, United States

University of California, San Diego La Jolla, California, United States

View Trial Details

Not Yet Recruiting

Low-Sodium Diet for Postpartum Blood Pressure Control

NCT07752056

Conditions: Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma

NCT07760454

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

Renji Hospital,Shanghai Jiao Tong University School Of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

Pomalidomide Plus Rituximab Maintenance in Young High-Risk Newly Diagnosed DLBCL After First-Line Response

NCT07760610

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma

NCT07759102

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Not Yet Recruiting

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

NCT07013435

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Mass General Hospital Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

NCT07313852

Conditions: B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Not Yet Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT07753369

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Henan Province Zhengzhou, Henan, China

Jiangsu Provincial People's Hospital Nanjing, Jiangsu, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions